The impact of AI in the workplace is already profound, but that impact is expected to grow exponentially in the coming years, ...

Charlotte Allerton, Pfizer's head of medicine design ... "The collaboration allows us to apply our expertise in molecular modelling, AI, and cloud computing towards improving existing ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

1. PostEra. PostEra Announces Expansion to $610M in Their AI Drug Discovery Collaboration with Pfizer. Press Release. Jan. 8, 2025. 2. PostEra. PostEra Provides Update on Progress of the ...

Boshoff has also worked as Pfizer’s head of development in Japan and as chief development officer for oncology and rare disease. “Dr. Boshoff is the ideal leader to propel Pfizer’s R&D ...

But Pfizer has, in front of it, an opportunity to make a very important announcement, and that is of the head of R&D. At the end of the day, bar farmer, the industry is driven by innovation.

Kennedy, Jr. Pfizer on Wednesday promoted its Chief Oncology Officer Chris Boshoff to head all R&D at the company, STAT’s Matthew Herper writes. Boshoff is taking over for Mikael Dolsten ...

The appointment of Boshoff as head of R&D also comes as Pfizer fends off activist investor Starboard Value, which has accused the company of running poor research and development operations ...

Charlotte Allerton, Pfizer's head of medicine design ... "The collaboration allows us to apply our expertise in molecular modelling, AI, and cloud computing towards improving existing ...